Home

Fai un esperimento Leonardoda strega chinese clinical oncology impact factor estratto Facciamolo Da

Home - Chinese Clinical Oncology
Home - Chinese Clinical Oncology

Journal of Clinical Oncology - Impact Factor, Overall Ranking, Rating,  h-index, Call For Paper, Publisher, ISSN, Scientific Journal Ranking (SJR),  Abbreviation, other Important Details | Resurchify
Journal of Clinical Oncology - Impact Factor, Overall Ranking, Rating, h-index, Call For Paper, Publisher, ISSN, Scientific Journal Ranking (SJR), Abbreviation, other Important Details | Resurchify

The dawn of China biopharma innovation | McKinsey
The dawn of China biopharma innovation | McKinsey

The dawn of China biopharma innovation | McKinsey
The dawn of China biopharma innovation | McKinsey

Chinese Society of Clinical Oncology|CSCO
Chinese Society of Clinical Oncology|CSCO

Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
Asia-Pacific Journal of Clinical Oncology - Wiley Online Library

Home - Chinese Clinical Oncology
Home - Chinese Clinical Oncology

Home - Chinese Clinical Oncology
Home - Chinese Clinical Oncology

State of Cancer Research Around the Globe
State of Cancer Research Around the Globe

Evaluating eligibility criteria of oncology trials using real-world data  and AI | Nature
Evaluating eligibility criteria of oncology trials using real-world data and AI | Nature

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China -  The Lancet Oncology
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China - The Lancet Oncology

Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
Asia-Pacific Journal of Clinical Oncology - Wiley Online Library

Frontiers | TCMIO: A Comprehensive Database of Traditional Chinese Medicine  on Immuno-Oncology | Pharmacology
Frontiers | TCMIO: A Comprehensive Database of Traditional Chinese Medicine on Immuno-Oncology | Pharmacology

Cancer drug development in China: recent advances and future challenges -  ScienceDirect
Cancer drug development in China: recent advances and future challenges - ScienceDirect

Archives - Chinese Clinical Oncology
Archives - Chinese Clinical Oncology

Characterization of the genomic landscape and actionable mutations in  Chinese breast cancers by clinical sequencing | Nature Communications
Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing | Nature Communications

Journal of Clinical Oncology: Vol 39, No 15_suppl
Journal of Clinical Oncology: Vol 39, No 15_suppl

American Society of Clinical Oncology | Choosing Wisely
American Society of Clinical Oncology | Choosing Wisely

Chinese Society of Clinical Oncology|CSCO
Chinese Society of Clinical Oncology|CSCO

Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
Asia-Pacific Journal of Clinical Oncology - Wiley Online Library

Peer-reviewed Oncology & Cancer Research Journal | Oncotarget
Peer-reviewed Oncology & Cancer Research Journal | Oncotarget

Six oncology breakthroughs from Mainland China: Takeaways from ASCO 2021 -  Clarivate
Six oncology breakthroughs from Mainland China: Takeaways from ASCO 2021 - Clarivate

Chinese Journal of Clinical Oncology
Chinese Journal of Clinical Oncology

About Annals of Oncology Impact factor: 32.976
About Annals of Oncology Impact factor: 32.976

Frontiers | In Real Life, Low-Level HER2 Expression May Be Associated With  Better Outcome in HER2-Negative Breast Cancer: A Study of the National  Cancer Center, China | Oncology
Frontiers | In Real Life, Low-Level HER2 Expression May Be Associated With Better Outcome in HER2-Negative Breast Cancer: A Study of the National Cancer Center, China | Oncology